Radiotherapy in bone sarcoma: the quest for better treatment option
Abstract Bone sarcomas are rare tumors representing 0.2% of all cancers. While osteosarcoma and Ewing sarcoma mainly affect children and young adults, chondrosarcoma and chordoma have a preferential incidence in people over the age of 40. Despite this range in populations affected, all bone sarcoma...
Main Authors: | Marie-Anaïs Locquet, Mehdi Brahmi, Jean-Yves Blay, Aurélie Dutour |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-11232-3 |
Similar Items
-
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study
by: Fred Hsu, et al.
Published: (2021-09-01) -
A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer
by: James Meehan, et al.
Published: (2021-08-01) -
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
by: Lydia Koi, et al.
Published: (2023-08-01) -
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
by: Silvia Pomella, et al.
Published: (2022-10-01) -
Radioresistance in rhabdomyosarcomas: Much more than a question of dose
by: Simona Camero, et al.
Published: (2022-09-01)